
GSK has lifted its sales and profits targets after a boost from HIV and oncology drugs as chief executive Dame Emma Walmsley prepares to leave the pharmaceutical giant.
Shares in the company rose on Wednesday morning as a result, lifting to their highest level for more than a year.